Evidence-based staging system for malignant melanoma: is new necessarily better?
Baron
Jens M
JM
Department of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen D-52074, Germany. jensmalte.baron@post.rwth-aachen.de
Abuzahra
Faris
F
D019317:Evidence-Based Medicine; D006801:Humans; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000401:mortality / Q000473:pathology* / Q000556:secondary; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology*; D015996:Survival Rate